Skip to content
thestock.space

On 6 Nov 2026, Vikas Lifecare was priced at ₹1.16, or 11.6× trailing earnings, against an industry P/E of 13.7×, and the shares are 44% below their 52-week high. It earns ROCE of 2.3% and ROE of 3.4%, and sales grew 1.6% a year over 3 years, though net profit is above operating profit, which points to a one-off gain. Debt is 0.19× equity. It is a small-cap company with a market cap of ₹215 Cr, ranked 20th of 81 Farm Products companies by market cap; the shares fell 42% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Mar 2026.How we calculate this

past year
Open
₹1.18
Day high
₹1.18
Day low
₹1.16
Prev. close
₹1.17
Volume
19.2 L

Health check

2 fair · 3 to check
  • ReturnsBehind

    −42.1% over a year, better than 0 of 7 peers.

  • Price tagDistorted

    A one-off gain inflates profit, so P/E isn’t comparable right now.

  • GrowthSteady

    Sales +1.6% a year over 3 years.

  • ProfitabilityWeak

    ROCE 2.3% vs peer median 10.6%.

  • Balance sheetFair

    Debt 0.19× equity, interest covered 2.1×, Piotroski 6 of 9.

  • Red flags4 to check

    Return on equity is low at 3.4%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Farm Products

80 listed peers. Screen the industry

Small cap

₹215 Cr, #20 of 81 in its industry by size.

Defensive

Beta 0.35 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Mar 2026: sales ₹499 Cr · profit ₹18 Cr
Market cap
₹215 Cr
Small cap
P/E
11.6
Industry 13.7
Price to book
0.40
Peers 1.92
Dividend yield
0.00%
ROE
3.4%
Peers 7.6%
ROCE
2.3%
Peers 10.6%
Debt to equity
0.19
Debt ₹105 Cr
EPS (TTM)
₹0.10
Face value ₹1
OPM (TTM)
−9.8%
Net margin 3.7%
Sales growth
+24.7%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
0.43
EV/EBITDA −8.3

Strengths and risks

Strengths

  • Quarterly sales up 24.7% on a year ago.

Risks to check

  • Return on equity is low at 3.4%.
  • Net profit is above operating profit, so a one-off gain is likely flattering earnings.
  • 44% below its 52-week high.
  • Interest coverage of only −7.4×.

Derived automatically from reported figures. Not a recommendation.

About Vikas Lifecare

Vikas Lifecare Limited engages in manufacturing and trading of polymers, chemicals, iron and steel, and plastic products in India and Ghana. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure segments. It offers various polymer compounds, including PE compounds, PVC compounds, V blend SOE compounds, polypropylene compounds, and thermo…

Headquarters
Delhi
Sector
Consumer Defensive
ISIN
INE161L01027
Website
vikaslifecarelimited.com

Price range

52 weeks

₹1.05₹2.08

Today

₹1.16₹1.18
Avg volume (3M)
22 L
1-year return
minus 42.1%
From 52-week high
minus 44.2%

Peers · Farm Products

Compare with peersScreen the whole industry
Company
AEROPLANEAmir Chand Jagdish Kumar (Exports)238.71minus 1.56%2,47219.92.4923.2%15.9%10.5%20.6%80.7%0.00%plus 32.6%
VENKEYSVenky's (India)1,587.90minus 1.21%2,23712.91.4012.1%9.1%6.0%−4.0%25.5%0.63%plus 4.5%
ANDREWYUAndrew Yule & Company23.47minus 2.21%1,148–3.55−4.7%−5.8%−27.2%−7.7%–0.00%minus 25.1%
PERVASIVEPervasive Commodities12.32minus 1.44%1,110––0.0%−0.1%−0.9%––0.00%plus 941.7%
APEXApex Frozen Foods324.45minus 1.14%1,01419.71.9210.6%7.6%7.7%−4.5%2.7%0.77%plus 39.0%
ZEALZeal Global Services69.45plus 4.99%876––33.8%14.7%4.0%22.5%26.0%–minus 39.9%
DBOLDhampur Bio Organics127.32minus 6.27%83525.30.827.7%2.5%6.5%−4.3%−39.0%1.18%plus 73.0%
VIKASLIFEVikas Lifecare1.16minus 0.85%21511.60.402.3%3.4%−9.8%1.6%–0.00%minus 42.1%
Median of 7 peers–−1.44%1,11019.81.9210.6%7.6%6.0%−4.2%25.5%0.32%32.6%

Quarterly results

Consolidated, ₹ crore · latest reported Mar 26
SalesSelect a row below to chart it
₹ CrMar 25Jun 25Sep 25Mar 26
13592.4141169
15595.3145195
−19.6−3−3.6−26.3
−14.5%−3.2%−2.6%−15.6%
22.71.7−11364.5
1.51.21.81.6
2.11.51.51.4
−4.8–––
−5.2−3.9−12035.3
46.1%−2.1%0.9%−17.9%
−2.9−4−11941.6
-0.02-0.02-0.640.22

Dec 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+1.6%
ROE
3.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
476446480499
–minus 6.4%+7.7%+4.0%
464441502548
11.84.3−21.7−48.4
2.5%1.0%−4.5%−9.7%
3.30.82067.9
2.32.74.56.5
33.66.75.9
−31.118.3––
−21.417.1−12.97.1
27.4%21.2%15.2%−157.3%
−15.314−10.618.4
-0.120.08-0.04–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
144165186186
187311346366
30.434.576.7105
93.143.5121103
455555729760
10393.58127.8
81.363.244.6–
77.118354405
11.315.87.961.1
182200542266
455555729760

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−112−41.7−222310
−36.6−90.6106−334
15113710819.6
1.74.2−8.1−4.7
−17.8−16−12.7−1.6
−130−57.7−235308

Shareholding pattern

Source: NSE filings
14.2%
promoters
  • Promoters14.20%
  • Public85.80%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202614.20%85.80%0.00
30 Jun 202614.20%85.80%0.00
31 Mar 202614.20%85.80%0.00
31 Dec 202514.20%85.80%0.00
30 Sep 202514.20%85.80%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you